Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.
SAN FRANCISCO--(BUSINESS WIRE)--OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results